NDC 50090-6322-01 - Glimepiride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6322
- Requested NDC
- 50090-6322-01
- Package NDCs from labels
- 50090-6322-1, 50090-6322-4, 50090-6322-2, 50090-6322-3, 50090-6322-0, 50090-6322-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-09-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glimepiride - A-S Medication Solutions | A-S Medication Solutions | 2023-09-06 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6322-0 | Glimepiride | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 50090-6322-1 | Glimepiride | 100 in 1 BOTTLE | TABLET | 100 | 3 | |
| 50090-6322-2 | Glimepiride | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 50090-6322-3 | Glimepiride | 90 in 1 BOTTLE | TABLET | 90 | 3 | |
| 50090-6322-4 | Glimepiride | 180 in 1 BOTTLE | TABLET | 180 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6322 | GLIMEPIRIDE TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, Legacy NDC, 5 package rows | 20230907_a11680ba-2750-43ab-a1b1-a52ebe3e139f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6322-0 | EA - Each | 50090-6322 | d8776c79-017f-4a41-a2ee-f77cb15fb1b8 | 1 | 2023-02-06 |
| 50090-6322-1 | EA - Each | 50090-6322 | 25485073-8362-4bda-953e-f01955ea6ea6 | 1 | 2023-02-06 |
| 50090-6322-2 | EA - Each | 50090-6322 | 7959c83d-25d7-473d-ad9c-0a4b56b04c53 | 1 | 2023-02-06 |
| 50090-6322-3 | EA - Each | 50090-6322 | 8176d336-f527-43a5-ada5-8db5c386b9c9 | 1 | 2023-02-06 |
| 50090-6322-4 | EA - Each | 50090-6322 | 14490013-f258-4fff-98a7-85dc565bb7aa | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glimepiride | GLIMEPIRIDE | Northwind Health Company, LLC | f3184cd3-df99-db32-e053-2995a90aa573 | 2026-01-01 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Northwind Health Company, LLC | dae404ac-881a-14d8-e053-2995a90acd41 | 2026-01-01 | Warnings, Adverse reactions | 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Northwind Health Company, LLC | 3e81a39a-30bb-4d6d-82e1-17d7134365be | 2026-01-01 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Northwind Health Company, LLC | f2f2d6da-eb40-4290-e053-2a95a90a6ca0 | 2026-01-01 | Warnings, Adverse reactions | 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | b6ce0eea-149d-4aed-a615-0b1c8f3f6a8e | 2025-12-30 | Warnings, Adverse reactions | ANDA202759 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Northwind Health Company, LLC | 10a36c79-1b24-46b7-e063-6294a90a8dca | 2025-12-26 | Warnings, Adverse reactions | ANDA202759 199246 6KY687524K |
| pioglitazone and glimepiride | PIOGLITAZONE AND GLIMEPIRIDE | Prasco Laboratories | ea385b3d-cb4c-4550-97b0-93a86533f6dc | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Accord Healthcare Inc | 9b74fbac-9e04-4927-9981-1e3dace89c6d | 2025-10-17 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 101cdc41-2131-4425-b550-6a0a60b5f4a4 | 2025-10-15 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 657f1b51-2f82-44f6-a23d-97f4b34b3c45 | 2025-10-15 | Warnings, Adverse reactions | 199245 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | 489dc098-0ac7-4f8e-b258-326229539c7c | 2025-08-15 | Warnings, Adverse reactions | ANDA202759 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | be7175ae-ba53-45b8-9554-e4f4ebf56883 | 2025-08-15 | Warnings, Adverse reactions | ANDA202759 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | BluePoint Laboratories | a01b0466-13f5-4c47-ae55-c5f1527d9414 | 2025-07-07 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | d4513181-4558-4d9a-851b-acf7e3eda25a | 2025-06-16 | Warnings, Adverse reactions | 199245 6KY687524K |
| Glimepiride | GLIMEPIRIDE | ST. MARY'S MEDICAL PARK PHARMACY | 35ba31ef-2b90-61c6-e063-6394a90a59ee | 2025-05-22 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Micro Labs Limited | 60e9397e-83b9-489e-9683-6f87e458bbaa | 2025-05-12 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | 49bf2d48-efa8-487b-b861-0124c3a4c951 | 2025-04-01 | Warnings, Adverse reactions | 199245 6KY687524K |
| Duetact | PIOGLITAZONE AND GLIMEPIRIDE | Takeda Pharmaceuticals America, Inc. | f8b0c917-3fdd-4a28-a47d-6225b8195458 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | 6KY687524K |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | f4ffb19e-6d65-49fd-83ce-514d38d9d97c | 2025-02-04 | Warnings, Adverse reactions | 199247 6KY687524K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.